Ad is loading...
FRCSX
Price
$67.30
Change
-$0.54 (-0.80%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

FRCSX vs VISVX

Header iconFRCSX vs VISVX Comparison
Open Charts FRCSX vs VISVXBanner chart's image
Franklin Small Cap Value R6
Price$67.30
Change-$0.54 (-0.80%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
FRCSX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRCSX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRCSX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. FRCSX (4.36B). VISVX pays higher dividends than FRCSX: VISVX (1.90) vs FRCSX (1.07). FRCSX was incepted earlier than VISVX: FRCSX (12 years) vs VISVX (27 years). FRCSX is a more actively managed with annual turnover of: 68.74 vs. VISVX (16.00). VISVX has a lower initial minimum investment than FRCSX: VISVX (3000) vs FRCSX (1000000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. FRCSX (25.35). VISVX return over 5 years is better than : 57.32 vs. FRCSX (30.55).
FRCSXVISVXFRCSX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years27 years-
Gain YTD16.94215.433110%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets4.36B57.6B8%
Annual Yield % from dividends1.071.9056%
Returns for 1 year25.3528.7188%
Returns for 3 years0.0713.231%
Returns for 5 years30.5557.3253%
Returns for 10 years14.40108.2113%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics